The advertisement promotes VITRAKVI, a medication for treating children's cancer caused by NTRK gene fusion, highlighting its potential as a chemo-free option and detailing important safety information regarding side effects.
Creative Information
| CID: | 982e21bb-3945-43b8-9ba9-8630932087d7 |
| CRID: | 82_1075-793351 |
| Domain: | vitrakvi-us.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $1.95 |
| Timestamp: | 11/10/2025, 6:37:42 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 9:01:06 PM | 7.80s | |
| adomain_analysis | success | 11/18/2025, 10:34:47 PM | 3.04s | |
| adomain_capture | success | 11/18/2025, 10:34:41 PM | 0.08s | |
| ad_render | success | 11/18/2025, 9:00:59 PM | 24.91s | |
| brand_mapping | success | 11/18/2025, 8:30:11 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: VITRAKVI
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1030.29 KB | ||||||||||||||||||||||
| Render Time: | 9.38 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1030.33 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
